Mrs. Madison Walker, M.S. Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 |
Madelyn Rebekah Stanfield, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 |
Landry Rehabilitation, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1223 Country Club Rd, Mcalester, OK 74501 Phone: 918-429-6734 |
Melissa Lucille Byrum, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 E Cherokee Ave, Mcalester, OK 74501 Phone: 405-641-3534 |
Joanne Ruth Hess, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 E Clark Bass Blvd, Mcalester, OK 74501 Phone: 918-426-1800 |
Michaela Sky Mass, CF-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 Fax: 918-423-2620 |
Kelbie Moon, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 |
Adams Rehabilitation, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 139, Mcalester, OK 74501 Phone: 918-823-4391 Fax: 918-823-4391 |
Thain's Speech Language Therapy, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7210 Thain Rd, Mcalester, OK 74501 Phone: 918-470-0541 |
Professional Speech Pathologists Of Mcalester, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 557 Broken Feather Ln, Mcalester, OK 74501 Phone: 918-916-1538 |
Ashley Brooke Monks, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 557 Broken Feather Lane, Mcalester, OK 74501 Phone: 918-916-1538 |
Amberly Wood Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 E Cherokee Ave, Mcalester, OK 74501 Phone: 918-421-9201 |
Kylie Jewell Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2220 |
Mrs. Lauren White, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 205 South 2nd, Mcalester, OK 74501 Phone: 918-421-9201 Fax: 918-423-2353 |
Clydeena Gaye Burrows, MS-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16 W Seneca Ave, Mcalester, OK 74501 Phone: 918-916-1904 |
Mrs. Deanna K Adams, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: Rr 2 Box 139, Mcalester, OK 74501 Phone: 918-823-4391 Fax: 918-823-4391 |
Natalie Elizabeth Rose Hart, M.S., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 E Clark Bass Blvd, Mcalester, OK 74501 Phone: 918-448-4471 Fax: 918-421-6612 |
Lisa J Manlove Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1400 E College Ave, Mcalester, OK 74501 Phone: 918-423-1267 |
Ashleigh Erica Higgins, CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1029 E Washington Ave, Mcalester, OK 74501 Phone: 918-423-2222 |
Melissa Byrum Speech Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 407 E Cherokee Ave, Mcalester, OK 74501 Phone: 405-641-3534 |
News Archive
New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults. Although those diseases, beta-thalassemia and polycythemia vera, have opposite effects on red blood cell production, treating animals with minihepcidin helps to restore normal levels of red blood cells and reduces spleen enlargement. It also controls the accumulation of excess levels of iron in beta-thalassemia that often causes severe toxic effects.
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced it is one of the three winners of the global Idiopathic Pulmonary Fibrosis (IPF) Catalyst Challenge, sharing the $1,000.000 (£720,000 GBP) award, each receiving $333,333 (£240,000 GBP).
Ampio Pharmaceuticals, Inc. (AMPE), a clinical stage biopharmaceutical company, with repurposed drugs and new molecular entities (NMEs) that treat inflammatory diseases, including osteoarthritis, diabetic macular edema (DME) and sexual dysfunction announced today that it has entered into a definitive agreement with Ethypharm Ltd for the manufacturing of Zertane, Ampio's drug for the treatment of premature ejaculation.
InterMune, Inc. announced that NASDAQ has today halted trading of InterMune's common stock. The Pulmonary-Allergy Drugs Advisory Committee to the U.S. Food and Drug Administration meets today to review and discuss the company's New Drug Application for pirfenidone for the treatment of patients with idiopathic pulmonary fibrosis.
› Verified 3 days ago